These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 1705823)

  • 1. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
    FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Arnold R
    Z Gastroenterol; 1990 Jul; 28(7):348-52. PubMed ID: 2238765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
    Siegel EG; Schulze A; Schmidt WE; Creutzfeldt W
    Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
    van der Burg MP; Guicherit OR; Frölich M; Gooszen HG
    Regul Pept; 1995 Dec; 60(1):61-7. PubMed ID: 8747785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
    Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas.
    Fehmann HC; Göke B; Weber V; Göke R; Trautmann ME; Richter G; Arnold R
    Pancreas; 1990 May; 5(3):361-5. PubMed ID: 1693001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
    Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
    Jia X; Elliott R; Kwok YN; Pederson RA; McIntosh CH
    Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
    Ding WG; Gromada J
    Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of galanin on islet cell secretory responses to VIP, GIP, 8-CCK, and glucagon by the perfused rat pancreas.
    Miralles P; Peiró E; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1988 Aug; 37(8):766-70. PubMed ID: 2457142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
    Oben J; Morgan L; Fletcher J; Marks V
    J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.